Galderma Group AG
GALD
주식 순위
#459
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
주가
$224.81
시가총액
$52.42B
변동 (1일)
6.31%
변동 (1년)
31.28%
국가
CH
거래 Galderma Group AG (GALD)
카테고리
Healthcare
Galderma Group AG (GALD)의 EPS
June 2026 기준 EPS TTM: $3.66
Galderma Group AG의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $3.66입니다. 2024년 말에는 회사의 EPS가 $1.07였으며, 이는 2023년의 EPS $-0.26와 증가입니다.
Galderma Group AG의 EPS 기록 (2021 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $3.66 | 34.56% |
| 2025 | $2.72 | 154.21% |
| 2024 | $1.07 | -511.54% |
| 2023 | $-0.26 | -39.53% |
| 2022 | $-0.43 | -33.85% |
| 2021 | $-0.65 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| $0.72 | -80.24% |
JP
|
|
| $0.56 | -84.80% |
IN
|
|
| $0.18 | -95.17% |
CN
|
